Causality assessment of spontaneously reported adverse drug events: Comparison of WHO-UMC criteria and Naranjo probability scale

International Journal of Risk and Safety in Medicine

Volumn 19, Issue 4, 2007, Pages 223-227

  Rehan, H S ^a   Chopra, Deepti ^a   Kakkar, Ashish Kumar ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

ADRs; Adverse event; Causality assessment; Naranjo probability scale; WHO UMC criteria

Indexed keywords

DRUG;

ARTICLE; COMPARATIVE STUDY; DRUG SURVEILLANCE PROGRAM; HUMAN; NARANJO PROBABILITY SCALE; RATING SCALE; UNSPECIFIED SIDE EFFECT; WORLD HEALTH ORGANIZATION;

EID: 36549088101     PISSN: 09246479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. T. Brewer and G.A Colditz, Postmarketing surveillance and adverse drug reactions: Current perspectives and future needs, J. Am. Med. Assoc. 281 (1999), 824-829.
2. U. Busto, C.A.U. Naranjo and E.M. Sellers, Comparison of two recently published algorithms for assessing the probability of adverse drug reactions, Br. J. Clin. Pharm. 13 (1982), 223-227.
3. D.C. Classen, S.L. Pestotnik, R.S. Evans and J.P. Burke, Computerized surveillance of adverse drug events in hospital patients, J. Am. Med. Assoc. 266 (1991), 2847-2851.
4. T.A. Hutchinson, J.M. Leventhal, M.S. Kramer, F.E. Karch, A.G. Lipman and A.R. Feinstein, An algorithm for the operational assessment of adverse drug reactions. II. Demonstration of reproducibility and validity, J. Am. Med. Assoc. 242 (1979), 633-638.
5. F.E. Karch and L. Lasagna, Towards the operational identification of adverse drug reactions, Clin. Pharmacol. Ther. 21 (1977), 247-254.
6. F. Karch, C. Smith, B. Kerzner, J. Mazullo, M. Weintraub and L. Lasagna, Adverse drug reaction - a matter of opinion, Clin. Pharmacol. Ther. 19 (1976), 489-492.
7. M.S. Kramer, J.M. Leventhal, T.A. Hutchinson and A.R. Feinstein, An algorithm for the operational assessment of adverse drug reactions. I. Background, description, and instructions for use, J. Am. Med. Assoc. 242 (1979), 623-632.
8. A.F. Macedo, F.B. Marques, C.F. Ribeiro and F. Teixeira, Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability, J. Clin. Pharmacol. Ther. 28 (2003), 137-143.
9. R.H. Meyboom, Y.A. Hekster, A.C. Egberts, F.W. Gribnau and I.R. Edwards, Causal or casual? The role of causality assessment in pharmacovigilance, Drug Saf. 17 (1997), 374-389.
10. C.A. Naranjo, U. Busto, E.M. Sellers, P. Sandor, I. Ruiz, E.A. Roberts, E. Janecek, C. Domecq and D.J. Greenblatt, A method for estimating the probability of adverse drug reactions, Clin. Pharmacol. Ther. 30 (1981), 239-245.
11. L.G. Schmidt, P. Dirschedl, R. Grohmann, J.U. Scherer, O. Wunderlich and B. Oerlinghausen Muller, Consistency of assessment of adverse drug reactions in psychiatric hospitals: a comparison of an algorithmic and an empirical approach, Eur. J. Clin. Pharmacol. 30 (1986), 199-204.
12. I. Tegeder, M. Levy, U. Muth-Selbach, R. Oelkers, F. Neumann, H. Dormann, T. Azaz-Livshits, M. Criegee-Rieck, H.T. Schneider, E. Hahn, K. Brune and G. Geisslinger, Retrospective analysis of the frequency and recognition of adverse drug reactions by means of automatically recorded laboratory signals, Br. J. Clin. Pharmacol. 47 (1999), 557-564.
13. J. Venulet and M. Ten Ham, Methods for monitoring and documenting adverse drug reactions, Int. J. Clin. Pharmacol. Ther. 34 (1996), 112-129.